J. Mehew, Rachel J. Johnson, David J Roberts, A. Griffiths, H. Harvala
{"title":"COVID - 19恢复期血浆:供体人口统计学因素相关的高中和抗体滴度","authors":"J. Mehew, Rachel J. Johnson, David J Roberts, A. Griffiths, H. Harvala","doi":"10.1111/tme.12868","DOIUrl":null,"url":null,"abstract":"Convalescent plasma containing high levels of SARS‐CoV‐2 antibodies has been studied as a possible treatment for COVID‐19. Better understanding of predictors of high antibody levels is needed for improving supply of high‐quality therapeutic plasma.","PeriodicalId":442504,"journal":{"name":"Transfusion Medicine (Oxford, England)","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres\",\"authors\":\"J. Mehew, Rachel J. Johnson, David J Roberts, A. Griffiths, H. Harvala\",\"doi\":\"10.1111/tme.12868\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Convalescent plasma containing high levels of SARS‐CoV‐2 antibodies has been studied as a possible treatment for COVID‐19. Better understanding of predictors of high antibody levels is needed for improving supply of high‐quality therapeutic plasma.\",\"PeriodicalId\":442504,\"journal\":{\"name\":\"Transfusion Medicine (Oxford, England)\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion Medicine (Oxford, England)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/tme.12868\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/tme.12868","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres
Convalescent plasma containing high levels of SARS‐CoV‐2 antibodies has been studied as a possible treatment for COVID‐19. Better understanding of predictors of high antibody levels is needed for improving supply of high‐quality therapeutic plasma.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
